MHI, the advisory panel, employees, and members of the Molecular Hydrogen Institute, furthermore referred to as “MHI”, hereby solemnly declare and promise to sustain the science of molecular hydrogen, to try our best to understand the scientific findings, search for answers, and accept the evidence as information comes to light.

MHI does not endorse claims that molecular hydrogen cures cancer or any disease. Although we do not yet know the true clinical effects of hydrogen, we do not discourage people from trying molecular hydrogen due to its high safety profile and possible benefits. However, we do discourage people from using molecular hydrogen at the expense of following recognized medical advice. 

MHI States and confirms the following to be true based on scientific evidence:

MHI does not endorse claims made by people who have become MHI certified. Any claim made outside of the MHI certification education is not sustained by MHI. To maintain the integrity of the science, MHI maintains the right to revoke certifications of persons who abuse or misrepresent the certifications by making claims contrary to MHI.

MHI is a 501(c)3, science-based, nonprofit whose mission is to provide education on, advance research about, and promotes awareness of molecular hydrogen’s therapeutic potential. 

MHI conflict of interest statement.

One concern about the name “Molecular Hydrogen Institute” is that it ostensibly gives the impression that we have already made the decision that hydrogen is clinically effective. This might inadvertently set up a confirmation bias to only look for supporting evidence and even dismiss contrary evidence. However, our objective is to simply determine the truth, as such we report on and publish all articles regardless of their therapeutic effect. In fact, we have published some null findings, which is helpful in advancing science because the more we learn what doesn’t work, the closer we come to determine what does work. 

However, some may argue that there is the potential of at least a perceived conflict of interest (COI) in our publications because we gain revenue from MHI educational activities or from donations that might bias our judgment to only focus on favorable effects. However, our education is not about using hydrogen therapy for the treatment or prevention of specific diseases but rather on educating about what even is molecular hydrogen (e.g., not alkaline water, or negative ions, etc.), and what the current clinical studies are reporting, as well as the underlying molecular mechanisms that mediate the biological effects. Nevertheless, a COI is often included in many of my publications because I have been remunerated for accepting speaking engagements in academic, medical, and commercial conferences.  

– MHI Founder, Tyler W. LeBaron, MSc., PhD.